Amlodipine and Nitric Oxide: No Clinically Significant Interactions
There are no clinically significant drug interactions between amlodipine and nitric oxide donors (such as nitrates), and these medications can be safely combined for the treatment of angina. In fact, the combination may provide complementary therapeutic benefits through different mechanisms of action.
FDA-Approved Safety Profile
The FDA drug label for amlodipine does not list nitric oxide donors or nitrates as contraindicated medications or as having significant drug interactions 1. The label specifically addresses drug interactions with various agents (CYP3A inhibitors, simvastatin, cyclosporine, tacrolimus, sildenafil) but makes no mention of concerns with nitrate co-administration.
Guideline-Supported Combination Therapy
European cardiology guidelines explicitly support combining calcium channel blockers like amlodipine with nitrates for angina management 2, 3. The 2018 expert consensus document notes that combining anti-ischemic drugs with additive or synergistic effects is often needed to control symptoms effectively 2.
The 2006 ESC guidelines specifically state that:
- Dihydropyridine calcium channel blockers (which includes amlodipine) are suitable for combination treatment with other anti-anginal agents 3
- The anti-anginal and anti-ischemic effects of calcium channel blockers are additive to those of other medications in many patients 3
- Long-term nitrates should be used together with other vasodilators in patients with chronic stable angina 2
Mechanistic Complementarity
The combination actually makes pharmacological sense:
Amlodipine enhances endogenous nitric oxide production through multiple mechanisms including increased eNOS phosphorylation and reduced oxidative stress 4, 5, 6. This is distinct from exogenous nitric oxide delivery via nitrate donors.
Nitrates work by providing exogenous NO after enzymatic conversion in vessel walls, predominantly causing venodilation at low doses and coronary artery dilation at higher doses 2.
These complementary mechanisms mean the drugs work synergistically rather than competitively.
Important Clinical Considerations
Blood Pressure Monitoring
While there is no pharmacokinetic interaction, both agents cause vasodilation and can lower blood pressure. Monitor blood pressure when initiating or adjusting doses of either medication, particularly in elderly patients or those with baseline hypotension. The FDA label notes amlodipine produces vasodilation resulting in blood pressure reduction 1.
Reflex Tachycardia
Nitrates can cause reflex sympathetic activation leading to increased heart rate 2. Amlodipine typically does not cause significant heart rate changes with chronic dosing 1, so this combination does not pose particular concerns for tachycardia compared to nitrates alone.
Avoid Confusion with PDE5 Inhibitors
Do not confuse this question with the well-known interaction between nitrates and PDE5 inhibitors (sildenafil, tadalafil). That is a different and dangerous interaction. The FDA label specifically notes that when amlodipine and sildenafil are combined, each independently exerts blood pressure lowering effects 1—this is mentioned separately from nitrate considerations.
Practical Application
For patients with chronic stable angina:
- Amlodipine can be safely prescribed alongside short-acting or long-acting nitrates
- Start with standard doses and titrate based on symptom control and blood pressure response
- The combination is particularly useful when monotherapy fails to adequately control anginal symptoms
- Consider adding a beta-blocker to the regimen to counteract nitrate-induced reflex tachycardia if it occurs 2